tiprankstipranks
Advertisement
Advertisement
Jacobio’s First-in-Human JAB-8263 Trial Moves Forward, Keeping Oncology Pipeline in Focus
PremiumCompany AnnouncementsJacobio’s First-in-Human JAB-8263 Trial Moves Forward, Keeping Oncology Pipeline in Focus
4M ago
Jacobio’s JAB-2485 Trial Progress: Early Cancer Data in Focus for HK:1167 Investors
Premium
Company Announcements
Jacobio’s JAB-2485 Trial Progress: Early Cancer Data in Focus for HK:1167 Investors
4M ago
Jacobio Strikes Up to US$1.9 Billion Global KRAS Inhibitor Deal With AstraZeneca
Premium
Company Announcements
Jacobio Strikes Up to US$1.9 Billion Global KRAS Inhibitor Deal With AstraZeneca
4M ago
Jacobio Pharmaceuticals Advances Cancer Treatment with JAB-23E73 Study
PremiumCompany AnnouncementsJacobio Pharmaceuticals Advances Cancer Treatment with JAB-23E73 Study
6M ago
Jacobio Pharmaceuticals Advances Cancer Treatment with JAB-30355 Study
Premium
Company Announcements
Jacobio Pharmaceuticals Advances Cancer Treatment with JAB-30355 Study
6M ago
Jacobio Pharmaceuticals Unveils Promising Preclinical Data for Pan-KRAS Inhibitor
Premium
Company Announcements
Jacobio Pharmaceuticals Unveils Promising Preclinical Data for Pan-KRAS Inhibitor
6M ago
Jacobio Pharmaceuticals Establishes Nomination Committee to Enhance Governance
PremiumCompany AnnouncementsJacobio Pharmaceuticals Establishes Nomination Committee to Enhance Governance
8M ago
Jacobio Pharmaceuticals Announces Board Meeting for Interim Results
Premium
Company Announcements
Jacobio Pharmaceuticals Announces Board Meeting for Interim Results
8M ago
Jacobio Pharmaceuticals Increases Concert Parties’ Shareholdings
Premium
Company Announcements
Jacobio Pharmaceuticals Increases Concert Parties’ Shareholdings
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100